Assessment of Myocardial Viability: Comparison of Echocardiography versus Cardiac Magnetic Resonance Imaging in the Current Era

Heart Lung and Circulation

Volumn 17, Issue 3, 2008, Pages 173-185

  Tomlinson, David R ^a   Becher, Harald ^a   Selvanayagam, Joseph B ^a,b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Cardiac magnetic resonance imaging; Dobutamine stress echocardiography; Myocardial contrast echocardiography; Myocardial viability; Tissue Doppler echocardiography

Indexed keywords

DOBUTAMINE; FLUORODEOXYGLUCOSE F 18; TECHNETIUM 99M; THALLIUM 201;

CONTRAST ECHOCARDIOGRAPHY; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HEART VOLUME; HUMAN; IMAGE QUALITY; INTERMETHOD COMPARISON; MITRAL VALVE REGURGITATION; MYOCARDIAL DISEASE; MYOCARDIAL HIBERNATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SCAR; SENSITIVITY AND SPECIFICITY; STRESS ECHOCARDIOGRAPHY; STUNNED HEART MUSCLE;

ECHOCARDIOGRAPHY; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL ISCHEMIA; SENSITIVITY AND SPECIFICITY;

EID: 43049174579     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2007.10.005     Document Type: Review

References (79)

1. Braunwald E., and Kloner R.A. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 66 6 (1982) 1146-1149
2. Rahimtoola S.H. The hibernating myocardium. Am Heart J 117 1 (1989) 211-221
3. Ross Jr. J. Myocardial perfusion-contraction matching. Implications for coronary heart disease and hibernation. Circulation 83 3 (1991) 1076-1083
4. Diamond G.A., Forrester J.S., deLuz P.L., Wyatt H.L., and Swan H.J. Post-extrasystolic potentiation of ischemic myocardium by atrial stimulation. Am Heart J 95 2 (1978) 204-209
5. Anderson J.L., Marshall H.W., Bray B.E., Lutz J.R., Frederick P.R., Yanowitz F.G., Datz F.L., Klausner S.C., and Hagan A.D. A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction. N Engl J Med 308 22 (1983) 1312-1318
6. Bolli R. Mechanism of myocardial "stunning". Circulation 82 3 (1990) 723-738
7. Bolli R. Myocardial 'stunning' in man. Circulation 86 6 (1992) 1671-1691
8. Schinkel A.F., Bax J.J., Boersma E., Elhendy A., Roelandt J.R., and Poldermans D. How many patients with ischemic cardiomyopathy exhibit viable myocardium?. Am J Cardiol 88 5 (2001) 561-564
9. Auerbach M.A., Schoder H., Hoh C., Gambhir S.S., Yaghoubi S., Sayre J.W., Silverman D., Phelps M.E., Schelbert H.R., and Czernin J. Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy. Circulation 99 22 (1999) 2921-2926
10. Bonow R.O. The hibernating myocardium: implications for management of congestive heart failure. Am J Cardiol 75 3 (1995) 17A-25A
11. Gewirtz H., Fischman A.J., Abraham S., Gilson M., Strauss H.W., and Alpert N.M. Positron emission tomographic measurements of absolute regional myocardial blood flow permits identification of nonviable myocardium in patients with chronic myocardial infarction. J Am Coll Cardiol 23 4 (1994) 851-859
12. Shivalkar B., Maes A., Borgers M., Ausma J., Scheys I., Nuyts J., Mortelmans L., and Flameng W. Only hibernating myocardium invariably shows early recovery after coronary revascularization. Circulation 94 3 (1996) 308-315
13. Selvanayagam J.B., Jerosch-Herold M., Porto I., Sheridan D., Cheng A.S., Petersen S.E., Searle N., Channon K.M., Banning A.P., and Neubauer S. Resting myocardial blood flow is impaired in hibernating myocardium: a magnetic resonance study of quantitative perfusion assessment. Circulation 112 21 (2005) 3289-3296
14. Vanoverschelde J.L., Wijns W., Depre C., Essamri B., Heyndrickx G.R., Borgers M., Bol A., and Melin J.A. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation 87 5 (1993) 1513-1523
15. Marinho N.V., Keogh B.E., Costa D.C., Lammerstma A.A., Ell P.J., and Camici P.G. Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization. Circulation 93 4 (1996) 737-744
16. Gerber B.L., Vanoverschelde J.L., Bol A., Michel C., Labar D., Wijns W., and Melin J.A. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. Circulation 94 4 (1996) 651-659
17. Becker L.C., Levine J.H., DiPaula A.F., Guarnieri T., and Aversano T. Reversal of dysfunction in postischemic stunned myocardium by epinephrine and postextrasystolic potentiation. J Am Coll Cardiol 7 3 (1986) 580-589
18. Bax J.J., Poldermans D., Elhendy A., Cornel J.H., Boersma E., Rambaldi R., Roelandt J.R., and Fioretti P.M. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol 34 1 (1999) 163-169
19. Bax J.J., Poldermans D., Elhendy A., Boersma E., and Rahimtoola S.H. Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol 26 2 (2001) 141-186
20. Rihal C.S., Raco D.L., Gersh B.J., and Yusuf S. Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations. Circulation 108 20 (2003) 2439-2445
21. Haas F., Haehnel C.J., Picker W., Nekolla S., Martinoff S., Meisner H., and Schwaiger M. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol 30 7 (1997) 1693-1700
22. Afridi I., Grayburn P.A., Panza J.A., Oh J.K., Zoghbi W.A., and Marwick T.H. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol 32 4 (1998) 921-926
23. Cwajg J.M., Cwajg E., Nagueh S.F., He Z.X., Qureshi U., Olmos L.I., Quinones M.A., Verani M.S., Winters W.L., and Zoghbi W.A. End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation: relation to rest-redistribution T1-201 tomography and dobutamine stress echocardiography. J Am Coll Cardiol 35 5 (2000) 1152-1161
24. Schinkel A.F., Poldermans D., Rizzello V., Vanoverschelde J.L., Elhendy A., Boersma E., Roelandt J.R., and Bax J.J. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?. J Thorac Cardiovasc Surg 127 2 (2004) 385-390
25. Pierard L.A., De Landsheere C.M., Berthe C., Rigo P., and Kulbertus H.E. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol 15 5 (1990) 1021-1031
26. Barilla F., Gheorghiade M., Alam M., Khaja F., and Goldstein S. Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization. Am Heart J 122 6 (1991) 1522-1531
27. Cigarroa C.G., deFilippi C.R., Brickner M.E., Alvarez L.G., Wait M.A., and Grayburn P.A. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 88 2 (1993) 430-436
28. Afridi I., Kleiman N.S., Raizner A.E., and Zoghbi W.A. Dobutamine echocardiography in myocardial hibernation: optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 91 3 (1995) 663-670
29. Yao S.S., and Chaudhry F.A. Assessment of myocardial viability with dobutamine stress echocardiography in patients with ischemic left ventricular dysfunction. Echocardiography 22 1 (2005) 71-83
30. Baumgartner H., Porenta G., Lau Y.K., Wutte M., Klaar U., Mehrabi M., Siegel R.J., Czernin J., Laufer G., Sochor H., Schelbert H., Fishbein M.C., and Maurer G. Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT: correlation with histopathology in explanted hearts. J Am Coll Cardiol 32 6 (1998) 1701-1708
31. Picano E., Lattanzi F., Orlandini A., Marini C., and L'Abbate A. Stress echocardiography and the human factor: the importance of being expert. J Am Coll Cardiol 17 3 (1991) 666-669
32. Hoffmann R., Lethen H., Marwick T., Arnese M., Fioretti P., Pingitore A., Picano E., Buck T., Erbel R., Flachskampf F.A., and Hanrath P. Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms. J Am Coll Cardiol 27 2 (1996) 330-336
33. Kloner R.A., Rude R.E., Carlson N., Maroko P.R., DeBoer L.W., and Braunwald E. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first?. Circulation 62 5 (1980) 945-952
34. Kaul S. Myocardial contrast echocardiography: 15 years of research and development. Circulation 96 10 (1997) 3745-3760
35. Skyba D.M., Camarano G., Goodman N.C., Price R.J., Skalak T.C., and Kaul S. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection. J Am Coll Cardiol 28 5 (1996) 1292-1300
36. Keller M.W., Segal S.S., Kaul S., and Duling B. The behavior of sonicated albumin microbubbles within the microcirculation: a basis for their use during myocardial contrast echocardiography. Circ Res 65 2 (1989) 458-467
37. deFilippi C.R., Willett D.L., Irani W.N., Eichhorn E.J., Velasco C.E., and Grayburn P.A. Comparison of myocardial contrast echocardiography and low-dose dobutamine stress echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemic heart disease. Circulation 92 10 (1995) 2863-2868
38. Nagueh S., Vaduganathan P., Ali N., Blaustein A., Verani M., Winters Jr. W., and Zoghbi W. Identification of hibernating myocardium: comparative accuracy of myocardial contrast echocardiography, rest-redistribution thallium-201 tomography and dobutamine echocardiography. J Am Coll Cardiol 29 5 (1997) 985-993
39. Wei K., Jayaweera A.R., Firoozan S., Linka A., Skyba D.M., and Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 97 5 (1998) 473-483
40. Korosoglou G., Hansen A., Hoffend J., Gavrilovic G., Wolf D., Zehelein J., Haberkorn U., and Kuecherer H. Comparison of real-time myocardial contrast echocardiography for the assessment of myocardial viability with fluorodeoxyglucose-18 positron emission tomography and dobutamine stress echocardiography. Am J Cardiol 94 5 (2004) 570-576
41. Senior R., and Swinburn J.M. Incremental value of myocardial contrast echocardiography for the prediction of recovery of function in dobutamine nonresponsive myocardium early after acute myocardial infarction. Am J Cardiol 91 4 (2003) 397-402
42. Jeetley P., Swinburn J., Hickman M., Bellenger N.G., Pennell D.J., and Senior R. Myocardial contrast echocardiography predicts left ventricular remodelling after acute myocardial infarction. J Am Soc Echocardiogr 17 10 (2004) 1030-1036
43. Sutherland G.R., Stewart M.J., Groundstroem K.W., Moran C.M., Fleming A., Guell-Peris F.J., Riemersma R.A., Fenn L.N., Fox K.A., and McDicken W.N. Color Doppler myocardial imaging: a new technique for the assessment of myocardial function. J Am Soc Echocardiogr 7 5 (1994) 441-458
44. Heimdal A., Stoylen A., Torp H., and Skjaerpe T. Real-time strain rate imaging of the left ventricle by ultrasound. J Am Soc Echocardiogr 11 11 (1998) 1013-1019
45. Weidemann F, Dommke C, Bijnens B, Claus P, D'Hooge J, Mertens P, Verbeken E, Maes A, Van de Werf F, De Scheerder I, Sutherland GR. Defining the transmurality of a chronic myocardial infarction by ultrasonic strain-rate imaging: implications for identifying intramural viability: an experimental study 10.1161/01.CIR.0000050146.66577.4B. Circulation 2003;107(6):883-8.
46. Chan J., Hanekom L., Wong C., Leano R., Cho G.Y., and Marwick T.H. Differentiation of subendocardial and transmural infarction using two-dimensional strain rate imaging to assess short-axis and long-axis myocardial function. J Am Coll Cardiol 48 10 (2006) 2026-2033
47. Hanekom L., Jenkins C., Jeffries L., Case C., Mundy J., Hawley C., and Marwick T.H. Incremental value of strain rate analysis as an adjunct to wall-motion scoring for assessment of myocardial viability by dobutamine echocardiography: a follow-up study after revascularization. Circulation 112 25 (2005) 3892-3900
48. Bjork Ingul C., Rozis E., Slordahl S.A., and Marwick T.H. Incremental value of strain rate imaging to wall motion analysis for prediction of outcome in patients undergoing dobutamine stress echocardiography. Circulation 115 10 (2007) 1252-1259
49. Pennell D.J., Underwood S.R., Manzara C.C., Swanton R.H., Walker J.M., Ell P.J., and Longmore D.B. Magnetic resonance imaging during dobutamine stress in coronary artery disease. Am J Cardiol 70 1 (1992) 34-40
50. Fayad Z.A., Connick T.J., and Axel L. An improved quadrature or phased-array coil for MR cardiac imaging. Magn Reson Med 34 2 (1995) 186-193
51. Simonetti O.P., Kim R.J., Fieno D.S., Hillenbrand H.B., Wu E., Bundy J.M., Finn J.P., and Judd R.M. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 218 1 (2001) 215-223
52. Kim R.J., Chen E.L., Lima J.A., and Judd R.M. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 94 12 (1996) 3318-3326
53. Kim R.J., Fieno D.S., Parrish T.B., Harris K., Chen E.L., Simonetti O., Bundy J., Finn J.P., Klocke F.J., and Judd R.M. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100 19 (1999) 1992-2002
54. Choi K.M., Kim R.J., Gubernikoff G., Vargas J.D., Parker M., and Judd R.M. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 104 10 (2001) 1101-1107
55. Gerber B.L., Garot J., Bluemke D.A., Wu K.C., and Lima J.A. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 106 9 (2002) 1083-1089
56. Kim R.J., Wu E., Rafael A., Chen E.L., Parker M.A., Simonetti O., Klocke F.J., Bonow R.O., and Judd R.M. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343 20 (2000) 1445-1453
57. Selvanayagam J.B., Kardos A., Francis J.M., Wiesmann F., Petersen S.E., Taggart D.P., and Neubauer S. Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation 110 12 (2004) 1535-1541
58. Lauerma K., Niemi P., Hanninen H., Janatuinen T., Voipio-Pulkki L.M., Knuuti J., Toivonen L., Makela T., Makijarvi M.A., and Aronen H.J. Multimodality MR imaging assessment of myocardial viability: combination of first-pass and late contrast enhancement to wall motion dynamics and comparison with FDG PET-initial experience. Radiology 217 3 (2000) 729-736
59. Wellnhofer E., Olariu A., Klein C., Grafe M., Wahl A., Fleck E., and Nagel E. Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation 109 18 (2004) 2172-2174
60. Kaandorp T.A., Bax J.J., Schuijf J.D., Viergever E.P., van Der Wall E.E., de Roos A., and Lamb H.J. Head-to-head comparison between contrast-enhanced magnetic resonance imaging and dobutamine magnetic resonance imaging in men with ischemic cardiomyopathy. Am J Cardiol 93 12 (2004) 1461-1464
61. Nagel E., Lehmkuhl H.B., Bocksch W., Klein C., Vogel U., Frantz E., Ellmer A., Dreysse S., and Fleck E. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 99 6 (1999) 763-770
62. Ricciardi M.J., Wu E., Davidson C.J., Choi K.M., Klocke F.J., Bonow R.O., Judd R.M., and Kim R.J. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 103 23 (2001) 2780-2783
63. Selvanayagam J.B., Porto I., Channon K., Petersen S.E., Francis J.M., Neubauer S., and Banning A.P. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging. Circulation 111 8 (2005) 1027-1032
64. Selvanayagam J.B., Petersen S.E., Francis J.M., Robson M.D., Kardos A., Neubauer S., and Taggart D.P. Effects of off-pump versus on-pump coronary surgery on reversible and irreversible myocardial injury: a randomized trial using cardiovascular magnetic resonance imaging and biochemical markers. Circulation 109 3 (2004) 345-350
65. Wagner A., Mahrholdt H., Holly T.A., Elliott M.D., Regenfus M., Parker M., Klocke F.J., Bonow R.O., Kim R.J., and Judd R.M. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 361 9355 (2003) 374-379
66. Geleijnse M.L., Fioretti P.M., and Roelandt J.R. Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. J Am Coll Cardiol 30 3 (1997) 595-606
67. Sharp S.M., Sawada S.G., Segar D.S., Ryan T., Kovacs R., Fineberg N.S., and Feigenbaum H. Dobutamine stress echocardiography: detection of coronary artery disease in patients with dilated cardiomyopathy. J Am Coll Cardiol 24 4 (1994) 934-939
68. Bigi R, Cortigiani L, Desideri A, Colombo P, Sponzilli C, Bax JJ, Fiorentini C. Clinical and angiographic correlates of dobutamine-induced wall motion patterns after myocardial infarction. Am J Cardiol 2001;88(9):944-8.
69. Cury R.C., Cattani C.A., Gabure L.A., Racy D.J., de Gois J.M., Siebert U., Lima S.S., and Brady T.J. Diagnostic performance of stress perfusion and delayed-enhancement MR imaging in patients with coronary artery disease. Radiology 240 1 (2006) 39-45
70. Klem I., Heitner J.F., Shah D.J., Sketch Jr. M.H., Behar V., Weinsaft J., Cawley P., Parker M., Elliott M., Judd R.M., and Kim R.J. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol 47 8 (2006) 1630-1638
71. Becher H, Chambers J, Fox K, Jones R, Leech GJ, Masani N, Monaghan M, More R, Nihoyannopoulos P, Rimington H, Senior R, Warton G. BSE procedure guidelines for the clinical application of stress echocardiography, recommendations for performance and interpretation of stress echocardiography: a report of the British Society of Echocardiography Policy Committee 10.1136/hrt.2004.047985. Heart 2004;90(Suppl 6):vi23-30.
72. Kaandorp T.A., Lamb H.J., van der Wall E.E., de Roos A., and Bax J.J. Cardiovascular MR to access myocardial viability in chronic ischaemic LV dysfunction. Heart 91 10 (2005) 1359-1365
73. Baer F.M., Theissen P., Crnac J., Schmidt M., Deutsch H.J., Sechtem U., Schicha H., and Erdmann E. Head to head comparison of dobutamine-transoesophageal echocardiography and dobutamine-magnetic resonance imaging for the prediction of left ventricular functional recovery in patients with chronic coronary artery disease. Eur Heart J 21 12 (2000) 981-991
74. 18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. Circulation 91 4 (1995) 1006-1015
75. 99mTc-tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium. Circulation 98 18 (1998) 1869-1874
76. Sayad D.E., Willett D.L., Hundley W.G., Grayburn P.A., and Peshock R.M. Dobutamine magnetic resonance imaging with myocardial tagging quantitatively predicts improvement in regional function after revascularization. Am J Cardiol 82 9 (1998) 1149-1151 A10
77. Baer F.M., Theissen P., Schneider C.A., Voth E., Sechtem U., Schicha H., and Erdmann E. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 31 5 (1998) 1040-1048
78. Sandstede J.J., Bertsch G., Beer M., Kenn W., Werner E., Pabst T., Lipke C., Kretschmer S., Neubauer S., and Hahn D. Detection of myocardial viability by low-dose dobutamine Cine MR imaging. Magn Reson Imaging 17 10 (1999) 1437-1443
79. Trent R.J., Waiter G.D., Hillis G.S., McKiddie F.I., Redpath T.W., and Walton S. Dobutamine magnetic resonance imaging as a predictor of myocardial functional recovery after revascularisation. Heart 83 1 (2000) 40-46